Trial Profile
A phase IV pharmacokinetic study of raltegravir in the semen of HIV infected men
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2016
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 27 Nov 2015 New trial record